Jubilant Ingrevia Share Price
Jubilant Ingrevia Ltd.
Today’s Low
Today’s High
52W Low
52W High
Open Price
Prev. Close
Volume
Value
Market Cap |
P/E Ratio |
P/B Ratio |
Industry P/E |
---|---|---|---|
Rs. 6074.98 Cr |
15.84 |
3.62 |
41.01 |
ROE |
EPS (TTM) |
Dividend Yield |
Book Value |
---|---|---|---|
25.43 % |
28.39 |
1.11 % |
135.49 |
All you have to do to buy Jubilant Ingrevia Ltd. share is download Nuuu app, create a demat account, and get your KYC documents verified online.
Yes you can buy Jubilant Ingrevia Ltd. shares, all you need is to have a verified demat account with Nuuu. And enjoy benefits like free brokerage credits and more.
As of 27 Mar`23 the Market Cap of Jubilant Ingrevia Ltd. is 6074.98.
As of 27 Mar`23 the PE is 15.84 and PB is 3.62.
The company's total revenue for the quarter ended September 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 12503.90 millions.The Company to register a -42.59% fall in the net profit for the quarter ended September 2022.The company reported a degrowth in operating Profit to 1439.80 millions from 2206.80 millions.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202209 | 202109 | % Var | 202209 | 202109 | % Var | 202203 | 202103 | % Var | |
Sales | 12503.90 | 12368.70 | 1.09 | 24080.50 | 23423.00 | 2.81 | 48604.20 | 6689.30 | 626.60 |
Other Income | 67.70 | 69.60 | -2.73 | 162.40 | 128.80 | 26.09 | 288.20 | 24.50 | 1076.33 |
PBIDT | 1439.80 | 2206.80 | -34.76 | 2949.10 | 4713.20 | -37.43 | 8418.40 | 992.80 | 747.95 |
Interest | 92.30 | 109.70 | -15.86 | 172.20 | 277.30 | -37.90 | 462.40 | 94.50 | 389.31 |
PBDT | 1347.50 | 2097.10 | -35.74 | 2776.90 | 4435.90 | -37.40 | 7956.00 | 768.90 | 934.72 |
Depreciation | 303.60 | 295.60 | 2.71 | 611.30 | 601.70 | 1.60 | 1201.30 | 213.50 | 462.67 |
PBT | 1043.90 | 1801.50 | -42.05 | 2165.60 | 3834.20 | -43.52 | 6754.70 | 555.40 | 1116.19 |
TAX | 340.30 | 575.90 | -40.91 | 697.60 | 1226.90 | -43.14 | 2232.20 | 169.50 | 1216.93 |
Deferred Tax | 126.00 | 266.40 | -52.70 | 255.00 | 563.30 | -54.73 | 1057.30 | 72.40 | 1360.36 |
PAT | 703.60 | 1225.60 | -42.59 | 1468.00 | 2607.30 | -43.70 | 4522.50 | 385.90 | 1071.94 |
Equity | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 |
PBIDTM(%) | 11.51 | 17.84 | -35.46 | 12.25 | 20.12 | -39.14 | 17.32 | 14.84 | 16.70 |
A decrease in the sales to Rs. 10905.10 millions was observed for the quarter ended December 2022. The sales stood at Rs. 12562.40 millions during the similar quarter previous year.Profit after Tax for the quarter ended December 2022 saw a decline of -41.95% from Rs. 1170.40 millions to Rs. 679.40 millions.The Operating Profit of the company witnessed a decrease to 1351.40 millions from 2081.50 millions.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 10905.10 | 12562.40 | -13.19 | 34985.60 | 35985.40 | -2.78 | 48604.20 | 6689.30 | 626.60 |
Other Income | 64.30 | 93.00 | -30.86 | 226.70 | 221.80 | 2.21 | 288.20 | 24.50 | 1076.33 |
PBIDT | 1351.40 | 2081.50 | -35.08 | 4300.50 | 6794.70 | -36.71 | 8418.40 | 992.80 | 747.95 |
Interest | 111.90 | 86.20 | 29.81 | 284.10 | 363.50 | -21.84 | 462.40 | 94.50 | 389.31 |
PBDT | 1239.50 | 1995.30 | -37.88 | 4016.40 | 6431.20 | -37.55 | 7956.00 | 768.90 | 934.72 |
Depreciation | 293.80 | 296.30 | -0.84 | 905.10 | 898.00 | 0.79 | 1201.30 | 213.50 | 462.67 |
PBT | 945.70 | 1699.00 | -44.34 | 3111.30 | 5533.20 | -43.77 | 6754.70 | 555.40 | 1116.19 |
TAX | 266.30 | 528.60 | -49.62 | 963.90 | 1755.50 | -45.09 | 2232.20 | 169.50 | 1216.93 |
Deferred Tax | 168.60 | 233.40 | -27.76 | 423.60 | 796.70 | -46.83 | 1057.30 | 72.40 | 1360.36 |
PAT | 679.40 | 1170.40 | -41.95 | 2147.40 | 3777.70 | -43.16 | 4522.50 | 385.90 | 1071.94 |
Equity | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 |
PBIDTM(%) | 12.39 | 16.57 | -25.21 | 12.29 | 18.88 | -34.90 | 17.32 | 14.84 | 16.70 |
The sales is pegged at Rs. 10905.10 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 12562.40 millions during the year-ago period.The Company to register a -41.95% fall in the net profit for the quarter ended December 2022.Operating profit for the quarter ended December 2022 decreased to 1351.40 millions as compared to 2081.50 millions of corresponding quarter ended December 2021.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 10905.10 | 12562.40 | -13.19 | 34985.60 | 35985.40 | -2.78 | 48604.20 | 6689.30 | 626.60 |
Other Income | 64.30 | 93.00 | -30.86 | 226.70 | 221.80 | 2.21 | 288.20 | 24.50 | 1076.33 |
PBIDT | 1351.40 | 2081.50 | -35.08 | 4300.50 | 6794.70 | -36.71 | 8418.40 | 992.80 | 747.95 |
Interest | 111.90 | 86.20 | 29.81 | 284.10 | 363.50 | -21.84 | 462.40 | 94.50 | 389.31 |
PBDT | 1239.50 | 1995.30 | -37.88 | 4016.40 | 6431.20 | -37.55 | 7956.00 | 768.90 | 934.72 |
Depreciation | 293.80 | 296.30 | -0.84 | 905.10 | 898.00 | 0.79 | 1201.30 | 213.50 | 462.67 |
PBT | 945.70 | 1699.00 | -44.34 | 3111.30 | 5533.20 | -43.77 | 6754.70 | 555.40 | 1116.19 |
TAX | 266.30 | 528.60 | -49.62 | 963.90 | 1755.50 | -45.09 | 2232.20 | 169.50 | 1216.93 |
Deferred Tax | 168.60 | 233.40 | -27.76 | 423.60 | 796.70 | -46.83 | 1057.30 | 72.40 | 1360.36 |
PAT | 679.40 | 1170.40 | -41.95 | 2147.40 | 3777.70 | -43.16 | 4522.50 | 385.90 | 1071.94 |
Equity | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 |
PBIDTM(%) | 12.39 | 16.57 | -25.21 | 12.29 | 18.88 | -34.90 | 17.32 | 14.84 | 16.70 |
The sales is pegged at Rs. 10905.10 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 12562.40 millions during the year-ago period.The Company to register a -41.95% fall in the net profit for the quarter ended December 2022.Operating profit for the quarter ended December 2022 decreased to 1351.40 millions as compared to 2081.50 millions of corresponding quarter ended December 2021.
(Rs. in Million) |
Quarter ended | Year to Date | Year ended | |||||||
202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
Sales | 10905.10 | 12562.40 | -13.19 | 34985.60 | 35985.40 | -2.78 | 48604.20 | 6689.30 | 626.60 |
Other Income | 64.30 | 93.00 | -30.86 | 226.70 | 221.80 | 2.21 | 288.20 | 24.50 | 1076.33 |
PBIDT | 1351.40 | 2081.50 | -35.08 | 4300.50 | 6794.70 | -36.71 | 8418.40 | 992.80 | 747.95 |
Interest | 111.90 | 86.20 | 29.81 | 284.10 | 363.50 | -21.84 | 462.40 | 94.50 | 389.31 |
PBDT | 1239.50 | 1995.30 | -37.88 | 4016.40 | 6431.20 | -37.55 | 7956.00 | 768.90 | 934.72 |
Depreciation | 293.80 | 296.30 | -0.84 | 905.10 | 898.00 | 0.79 | 1201.30 | 213.50 | 462.67 |
PBT | 945.70 | 1699.00 | -44.34 | 3111.30 | 5533.20 | -43.77 | 6754.70 | 555.40 | 1116.19 |
TAX | 266.30 | 528.60 | -49.62 | 963.90 | 1755.50 | -45.09 | 2232.20 | 169.50 | 1216.93 |
Deferred Tax | 168.60 | 233.40 | -27.76 | 423.60 | 796.70 | -46.83 | 1057.30 | 72.40 | 1360.36 |
PAT | 679.40 | 1170.40 | -41.95 | 2147.40 | 3777.70 | -43.16 | 4522.50 | 385.90 | 1071.94 |
Equity | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 | 159.30 | 159.30 | 0.00 |
PBIDTM(%) | 12.39 | 16.57 | -25.21 | 12.29 | 18.88 | -34.90 | 17.32 | 14.84 | 16.70 |
The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022
Jubilant Ingrevia is currently trading at Rs. 474.90, up by 3.55 points or 0.75% from its previous closing of Rs. 471.35 on the BSE.
The scrip opened at Rs. 468.00 and has touched a high and low of Rs. 483.90 and Rs. 467.75 respectively. So far 18256 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 877.95 on 18-Oct-2021 and a 52 week low of Rs. 401.35 on 08-Mar-2022.
Last one week high and low of the scrip stood at Rs. 487.05 and Rs. 456.50 respectively. The current market cap of the company is Rs. 7645.49 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 10.89% and 37.64% respectively.
Jubilant Ingrevia has raised Rs 50 crore through issuance of Commercial Papers (CPs) on August 30, at a coupon rate of 6.05% per annum. The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Jubilant Ingrevia has informed that Commercial Papers (CP) of Rs 50 Crore, bearing ISIN INE0BY014094, issued on August 30, 2022, has been fully redeemed by the Company on October 28, 2022 the maturity date. The Corporate Action confirmation letter for redemption of Commercial Papers has been received by the Company on November 02, 2022.
The above information is a part of company’s filings submitted to BSE.
Jubilant Ingrevia has informed about the Record Date for maturity of the Commercial Papers (‘CPs’) issued by the Company as details enclosed.
The above information is a part of company’s filings submitted to BSE.
In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Jubilant Ingrevia has informed that it enclosed Confirmation Certificate for the quarter ended December 31, 2022 received from Alankit Assignments, Registrar and Share Transfer Agent of the Company.
The above information is a part of company’s filings submitted to BSE.
The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023
Jubilant Ingrevia is currently trading at Rs. 469.50, up by 0.55 points or 0.12% from its previous closing of Rs. 468.95 on the BSE.
The scrip opened at Rs. 467.20 and has touched a high and low of Rs. 476.00 and Rs. 465.10 respectively. So far 73755 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 401.35 on 08-Mar-2022.
Last one week high and low of the scrip stood at Rs. 481.75 and Rs. 464.90 respectively. The current market cap of the company is Rs. 7506.12 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 13.28% and 35.24% respectively.
Jubilant Ingrevia has raised Rs 150 crore through issuance of Commercial Papers (CPs) on February 09, 2023, at a coupon rate of 7.12% per annum. The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Aggregate consideration for acquisition of additional shares is Rs 2.12 crore
Jubilant Ingrevia is currently trading at Rs. 412.90, up by 15.60 points or 3.93% from its previous closing of Rs. 397.30 on the BSE.
The scrip opened at Rs. 400.45 and has touched a high and low of Rs. 420.20 and Rs. 400.45 respectively. So far 13370 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 592.45 on 11-Nov-2022 and a 52 week low of Rs. 395.65 on 16-Mar-2023.
Last one week high and low of the scrip stood at Rs. 440.95 and Rs. 395.65 respectively. The current market cap of the company is Rs. 6505.84 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 13.29% and 35.24% respectively.
Jubilant Ingrevia has acquired 37.98% stake of Mister Veg Foods, an associate company of the Company. This further investment is towards potential synergies with the Nutrition business of the Company. Aggregate consideration for acquisition of additional shares is Rs 2.12 crore. The acquisition is completed on March 16, 2023.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Rs.2.5000 per share(250%)Interim Dividend
Quarterly Results
Quarterly Results
Final Dividend & Audited Results
Inter alia, to consider change in Terms and Conditions including early redemption/ buyback of 1,000 7.90% Secured, Rated, Listed, Redeemable NonConvertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore
Rs.2.5000 per share(250%)Interim Dividend
Quarterly Results & Interim Dividend
Inter alia, to consider buy-back of 1,000 7.90% Secured, Rated, Listed, Redeemable Non- Convertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore.
Quarterly Results
Quarterly Results
The tenure of instrument is 46 days and hence the maturity will be on October 10
Jubilant Ingrevia has raised Rs 50 crore through issuance of Commercial Papers (CPs) on August 25, at a coupon rate of 6.05% per annum. The tenure of instrument is 46 days and hence the maturity will be on October 10.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022
Jubilant Ingrevia has raised Rs 50 crore through issuance of Commercial Papers (CPs) on August 30, at a coupon rate of 6.05% per annum. The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023
Jubilant Ingrevia has raised Rs 150 crore through issuance of Commercial Papers (CPs) on February 09, 2023, at a coupon rate of 7.12% per annum. The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
Aggregate consideration for acquisition of additional shares is Rs 2.12 crore
Jubilant Ingrevia has acquired 37.98% stake of Mister Veg Foods, an associate company of the Company. This further investment is towards potential synergies with the Nutrition business of the Company. Aggregate consideration for acquisition of additional shares is Rs 2.12 crore. The acquisition is completed on March 16, 2023.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.